Three insights:
1. Tactoset is intended for the treatment of bone voids and other bone defects caused by trauma or age-related degeneration.
2. The therapy fuses calcium phosphate with Anika’s hyaluronic acid to enhance procedural efficiency and ease of use.
3. Tactoset is provided in a kit with an aqueous solution in a pre-loaded syringe and a dry powder that must be mixed intraoperatively to form a cohesive paste prior to administration.
More articles on devices:
6 hospitals adding robotic systems for spine, orthopedics
Royal Biologics launches allograft for spine, neurosurgery
17 patients sue Mizzou BioJoint Center over knee replacement failures
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
